Clinical trial
Dasatinib for HIV-1 Reservoir Reduction
NCT07342491 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dasatinib for HIV-1 Reservoir Reduction
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- May 8, 2026
- Completion date
- May 12, 2027
- Enrollment
- 14 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.